Infusion Pump Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user and Region

The demand for infusion pumps is being driven by a rising number of hospitalizations, increasing prevalence of chronic diseases, and the growing aging patient population worldwide. The global infusion pump market is expected to experience significant growth in the future, fueled by the rising number of patients with conditions such as diabetes and gastrointestinal diseases. The mainstream adoption of home-based healthcare settings will also contribute to market growth, particularly with the growing popularity of portable infusion pumps in home health settings. The combination of home healthcare and portable infusion pumps offers cost efficiency, further driving market expansion.

In addition to home health settings, infusion pumps will continue to be adopted in hospitals, clinics, infusion clinics, and ambulatory surgical centers. The increasing number of long-term care facilities and palliative care centers will also contribute to the growth of the infusion pump market. The COVID-19 pandemic has accelerated the adoption of home-based healthcare, and government efforts in this direction will further drive the demand for infusion pumps.

The soaring global burden of diabetes and cancers significantly influences the market growth. The global cancer burden is projected to increase by 40% by 2040 compared to 2020, leading to a growing need for palliative care at home and driving the demand for infusion pumps. The increasing use of chemotherapy procedures in hospitals and cancer specialty centers, along with the availability of technologically advanced ambulatory infusion pumps, will further boost demand within the oncology segment.

While the medical industry has made advancements in sophistication, there are challenges that hinder the complete reliability of infusion pumps. Poor wireless connectivity and lack of interoperability among infusion devices and hospital systems remain key impediments. However, the market for refurbished and rental infusion pumps is expected to witness notable demand from small healthcare facilities and budget-constrained hospitals.

North America dominates the infusion pump market, with the US being the early adopter of specialty infusion pumps. The sustained preference for specialty infusion pumps in the treatment of chronic health conditions will uphold the market in the region. The strong presence of key manufacturers and state-of-the-art healthcare infrastructure further strengthens market expansion in North America. Asia Pacific presents ample opportunities for infusion pump manufacturers, with the region experiencing alarming rates of chronic disease prevalence. The improving healthcare expenditure, accelerating healthcare infrastructure development, and low-cost manufacturing benefits make Asia Pacific an attractive market for leading brands and investors.

The report will provide a competition analysis section covering key players in the infusion pump market. Some of the key companies to be profiled include B. Braun Melsungen AG, Medtronic PLC, Baxter International Inc., Becton, Dickinson and Company, Roche Diagnostics, Fresenius SE & Co., Smiths Medical, Johnson & Johnson, ICU Medical, Inc., CME Medical UK Limited, Inc., Avanos Medical, Moog, Inc., Terumo Corporation, Teleflex, Inc., Nipro Corporation, Insulet Corporation, Zyno Medical LLC, and Shenzhen MedRena Biotech Co., Ltd.